cetylpyridinium chloride anhydrous has been researched along with Restless Leg Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giannaki, CD; Hadjigeorgiou, GM; Karatzaferi, C; Koukoulis, GN; Koutedakis, Y; Lavdas, E; Liakopoulos, V; Sakkas, GK; Stefanidis, I; Tsianas, N | 1 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and Restless Leg Syndrome
| Article | Year |
|---|---|
Evidence of increased muscle atrophy and impaired quality of life parameters in patients with uremic restless legs syndrome.
Topics: Body Composition; Female; Health; Humans; Male; Middle Aged; Muscular Atrophy; Quality of Life; Renal Dialysis; Restless Legs Syndrome; Sleep; Surveys and Questionnaires; Uremia | 2011 |